Quest Diagnostics Incorporated (BMV:DGX)

Market Cap	366.28B -1.4%
Revenue (ttm)	198.67B +11.8%
Net Income	17.79B +13.9%
EPS	157.53 +13.8%
Shares Out	n/a
PE Ratio	20.59
Forward PE	17.70
Dividend	59.39 (1.62%)
Ex-Dividend Date	Apr 6, 2026

Volume	242
Average Volume	1,084
Open	3,657.00
Previous Close	3,330.00
Day's Range	3,657.00 - 3,657.00
52-Week Range	3,132.50 - 3,657.00
Beta	n/a
RSI	62.25
Earnings Date	Apr 21, 2026

About Quest Diagnostics

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceu...

• Industry: Medical Laboratories
• Founded: 1967
• Employees: 51,500
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: DGX

Financial Performance

In 2025, Quest Diagnostics's revenue was $11.04 billion, an increase of 11.78% compared to the previous year's $9.87 billion. Earnings were $988.00 million, an increase of 14.09%.

Financial numbers in USD